AKT1 and periodontitis: In vitro experiments demonstrated that GelMA@G-Rb3 effectively regulates the inflammatory response in periodontitis by modulating the MAPK/PI3K-AKT signaling pathway, significantly suppressing the expression of pro-inflammatory factors while promoting the production of anti-inflammatory factors.